<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04687826</url>
  </required_header>
  <id_info>
    <org_study_id>GDFT1517</org_study_id>
    <nct_id>NCT04687826</nct_id>
  </id_info>
  <brief_title>Perioperative Fluid Therapy in Patients Undergoing Pancreaticoduodenectomy</brief_title>
  <official_title>Perioperative Fluid Therapy in Patients Undergoing Pancreaticoduodenectomy - How to Reduce Postoperative Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative complication rates in patients undergoing pancreaticoduodenectomy remain high&#xD;
      although the operation techniques have developed a lot in recent years. There is evidence&#xD;
      that restrictive intraoperative fluid therapy could decrease postoperative complication rates&#xD;
      but the results of the former studies have been somewhat controversial. The aim of this study&#xD;
      is to examine whether the intraoperative and postoperative fluid therapy affect to the&#xD;
      postoperative complication rates in patients undergoing pancreaticoduodenectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a retrospective cohort study. The first cohort consists of patients who&#xD;
      underwent pancreaticoduodenectomy in year 2015 when intraoperative fluid therapy were managed&#xD;
      using goal directed fluid therapy technique. The second cohort consists of patients who&#xD;
      underwent pancreaticoduodenectomy in year 2017 when intraoperative fluid therapy were based&#xD;
      on the consideration of the anaesthesiologist. In 2015 most of the patients spent the first&#xD;
      postoperative night in the ICU where the fluid management and monitoring of the urine output&#xD;
      and vital functions were more controlled than in the normal ward. In 2017 most of the&#xD;
      patients got in the regular ward right after the surgery. The aim of the study is to examine&#xD;
      whether there are differences in the amounts of the intraoperative and postoperative fluids&#xD;
      between the cohorts and does the perioperative fluid therapy affect to the complication&#xD;
      rates.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">November 20, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative fluid volume</measure>
    <time_frame>The duration of the surgery</time_frame>
    <description>The amount of fluid (crystalloids and albumin) patients got during the surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative complications (Clavien-Dindo classification)</measure>
    <time_frame>Postoperative day 0-30</time_frame>
    <description>The rate of severe Clavien-Dindo complications (3-5)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severe surgical complications</measure>
    <time_frame>Postoperative day 0-30</time_frame>
    <description>The rate of surgical complications (Clavien Dindo 3-5), without cardiopulmonary complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary complications</measure>
    <time_frame>Postoperative day 0-30</time_frame>
    <description>The rate of cardiopulmonary complications e.g., congestive heart failure, pleural effusion, dyspnea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pancreatic fistulas</measure>
    <time_frame>Postoperative day 0-30</time_frame>
    <description>The rate of severe pancreatic fistulas (grade B-C)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative fluid volume</measure>
    <time_frame>Postoperative day 0-3</time_frame>
    <description>The amount of fluid patients got postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative fluid balance</measure>
    <time_frame>The duration of the surgery</time_frame>
    <description>The change in intraoperative fluid intake (crystalloids, colloids, blood products) and fluid output (urine output, blood loss, evaporation) in millilitres and ml/kg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative fluid balance</measure>
    <time_frame>Postoperative day 1-3</time_frame>
    <description>The change in postoperative fluid intake (crystalloids, colloids, blood products) and fluid output (urine output, secretion in drains etc.) in millilitres.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">168</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Pancreaticoduodenectomy in 2015</arm_group_label>
    <description>Patients who underwent pancreaticoduodenectomy in 2015 got intraoperative fluid therapy in goal directed fluid therapy technique. Most of the patients spent the first postoperative night in ICU where the monitoring of urine output and fluid balance are more specific than in a normal ward.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pancreaticoduodenectomy in 2017</arm_group_label>
    <description>Patients who underwent pancreaticoduodenectomy in 2017 got liberal intraoperative fluid therapy and most of the patients spent the first postoperative night in a regular ward.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Goal directed fluid therapy</intervention_name>
    <description>Patients in 2015 got intraoperative fluid therapy in goal directed fluid therapy technique.</description>
    <arm_group_label>Pancreaticoduodenectomy in 2015</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liberal fluid therapy</intervention_name>
    <description>Patients in 2017 got liberal intraoperative fluid therapy influenced by their anaesthesiologist.</description>
    <arm_group_label>Pancreaticoduodenectomy in 2017</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who have underwent pancreaticoduodenectomy in years 2015 and 2017 are counted&#xD;
        in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18 or over&#xD;
&#xD;
          -  patients who underwent pancreaticoduodenectomy in 2015 or in 2017&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients whose patient record information is insufficient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piia Peltoniemi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 20, 2020</study_first_submitted>
  <study_first_submitted_qc>December 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Piia Peltoniemi</investigator_full_name>
    <investigator_title>M.D. Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>pancreaticoduodenectomy</keyword>
  <keyword>Clavien-Dindo classification</keyword>
  <keyword>pancreatic fistulas</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

